NIFTY 50

Sun Pharma replaces formulations distributor with own unit

Updated : January 22, 2019 11:32 AM IST

The company had last week asked capital market regulator Securities and Exchange Board of India (SEBI) to look into a media report about an alleged complaint by a whistleblower relating to certain transactions involving the company and its co-promoter that had led to a sell-off in the company's shares.
The drugmaker also denied giving any loans or guarantees to Suraksha Realty, adding that it does not have any financial deals with the Mumbai-based company.
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

You May Also Like

Live TV